PedAM
Pediatric Disease Annotations & Medicines
| Disease | cardiogenic shock |
| Phenotype | C0027051|myocardial infarct |
| Sentences | 155 |
| PubMedID- 23613700 | Suspicious of non st-segment elevation myocardial infarction combined with cardiogenic shock, we performed coronary angiography. |
| PubMedID- 22062683 | Background: the effectiveness of pcps for acute myocardial infarction (ami) complicated with cardiogenic shock has been reported, but there are few reports on the use of pcps for massive pe with circulatory collapse. |
| PubMedID- 20515862 | A 60-year-old man was admitted to our department with non st-segment elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23472937 | The use of iabp counterpulsation did not significantly reduce 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock for whom an early revascularization strategy was planned. |
| PubMedID- 19770739 | Objective: patients undergoing percutaneous coronary intervention (pci) for acute myocardial infarction with cardiogenic shock (cs) are often treated with intra-aortic balloon pump counterpulsation (iabp), even though the evidence to support this is limited. |
| PubMedID- 25819870 | Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial. |
| PubMedID- 21849830 | myocardial infarction complicated by cardiogenic shock: a possible role for the impella device. |
| PubMedID- 24876220 | cardiogenic shock associated with significant myocardial infarction during the early postoperative period is rare. |
| PubMedID- PMC2934137 | In myocardial infarction complicated by cardiogenic shock, levels of bnp and nt-probnp both provide valuable additional information. |
| PubMedID- 23622904 | The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis. |
| PubMedID- 26148217 | Acute myocardial infarction complicated by cardiogenic shock: an algorithm-based extracorporeal membrane oxygenation program can improve clinical outcomes. |
| PubMedID- 21132310 | Patients were eligible for participation if they were presenting with cardiogenic shock because of acute myocardial infarction and if primary pci could be successfully performed. |
| PubMedID- 24011548 | Interpretation: in patients undergoing early revascularisation for myocardial infarction complicated by cardiogenic shock, iabp did not reduce 12 month all-cause mortality. |
| PubMedID- 23096512 | [clinical characteristics, management and prognostic evolution of patients admitted within six hours of symptom onset with st-segment elevation acute myocardial infarction complicated by cardiogenic shock : twenty year monocentric study]. |
| PubMedID- 25830921 | Unverzagt s, machemermt, solms a, thiele h, burkhoff d, seyfarthm, dewaha a, ohman em, buerke m, haerting j, werdan k, prondzinsky r. intra-aortic balloon pump counterpulsation (iabp) for myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 21910914 | Marenzi et al [38] found that in the setting of st-elevation acute myocardial infarction, complicated by cardiogenic shock, aki occurred in 55% of patients. |
| PubMedID- 24133510 | One-year clinical outcomes in invasive treatment strategies for acute st-elevation myocardial infarction complicated by cardiogenic shock in elderly patients. |
| PubMedID- 25812932 | Intra-aortic balloon pump counterpulsation (iabp) for myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 25528363 | Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial. |
| PubMedID- 23147461 | Drug-eluting stents should not be used in st-elevated myocardial infarction with cardiogenic shock. |
| PubMedID- 21829053 | Material and methods: the course of acute myocardial infarction complicated by cardiogenic shock in patients with aortic counterpulsation was analyzed. |
| PubMedID- 24105454 | Objectives: we investigated the clinical impact of multivessel percutaneous coronary intervention in st-segment elevation myocardial infarction complicated by cardiogenic shock with multivessel disease. |
| PubMedID- 25637294 | Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock: an analysis from the iabp-shock ii-trial. |
| PubMedID- 24075314 | Aim: to assess the impact on in-hospital and long-term survival of thrombus aspiration (ta) during primary percutaneous coronary intervention (ppci) for st-segment elevation myocardial infarction (stemi) complicated by cardiogenic shock (cs). |
| PubMedID- 24748798 | This case is an example of a patient who had an in-hospital cardiac arrest due to acute myocardial infarction, complicated by cardiogenic shock. |
| PubMedID- 23312972 | Peripheral venoarterial extracorporeal membrane oxygenation improves survival in myocardial infarction with cardiogenic shock. |
| PubMedID- 24133520 | Acute myocardial infarction complicated by cardiogenic shock and left main coronary artery disease is called left main shock syndrome. |
| PubMedID- 26288729 | Based on the clinical findings, ecg changes and transthoracic echo findings, acute transmural posterior wall myocardial infarction with cardiogenic shock was assumed to be the cause of circulatory arrest. |
| PubMedID- 22569335 | Although recent meta-analyses challenge current aha/acc/esc guidelines, adequately powered randomized studies are needed to elucidate the role of iabp in patients with acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 20606428 | Methods: between may 2001 and december 2009, 212 consecutive patients with anterior-wall st-elevation myocardial infarction complicated by cardiogenic shock due to lad (n = 97) occlusion (group 1) and lcx or rca (n = 115) occlusion (group 2) undergoing primary pci were enrolled. |
| PubMedID- 25183544 | There is limited clinical data comparing different p2y12-receptor inhibitors in patients with acute myocardial infarction (ami) complicated by cardiogenic shock. |
| PubMedID- 25976448 | However, its impact on on-treatment platelet reactivity and clinical outcome in patients with acute myocardial infarction (ami) complicated by cardiogenic shock and undergoing pci with p2y12 receptor inhibitor treatment is less clear. |
| PubMedID- 24362653 | myocardial infarction complicated with cardiogenic shock had very high mortality (83.33%). |
| PubMedID- 22787475 | However, cardiogenic shock with myocardial infarction resulting from simultaneous multiple coronary artery spasm has been rarely reported, and not in korea. |
| PubMedID- 24512409 | Rituximab-vincristine chemotherapy-induced acute anterior wall myocardial infarction with cardiogenic shock. |
| PubMedID- 24380840 | In clinical routine, iabp is mainly used in high-risk patients with acute myocardial infarction, especially when complicated by cardiogenic shock. |
| PubMedID- 23905448 | Objective: to determine the outcomes of primary percutaneous coronary intervention for st elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23587133 | Studied the usefulness of pre-hospital triage with regard to treatment delay and mortality in patients with st-elevation myocardial infarction (stemi) complicated by cardiogenic shock referred for primary percutaneous coronary intervention [22]. |
| PubMedID- 20690098 | Intra-aortic balloon pumps (iabp) are commonly used in the setting of an acute myocardial infarction that is complicated by cardiogenic shock or mechanical complications such as a ventricular septal defect or papillary muscle rupture. |
| PubMedID- 26377638 | Acute myocardial infarction complicated by cardiogenic shock: results of primary percutaneous coronary interventions are insufficient. |
| PubMedID- 22572491 | Background: mortality in acute myocardial infarction (ami) complicated by cardiogenic shock (cs) approaches 70 - 80%, regardless of the type of pharmacological treatment. |
| PubMedID- 20732481 | Background: the mortality rate of patients experiencing acute myocardial infarction (ami) complicated by cardiogenic shock remains high. |
| PubMedID- 23233759 | Six months post implant he experienced acute inferolateral st-segment elevation myocardial infarction complicated by cardiogenic shock and underwent successful primary percutaneous revascularization. |
| PubMedID- 21779281 | St elevation myocardial infarction with cardiogenic shock was more prevalent in the non-survivors than in the survivors (75% vs. |
| PubMedID- 22001778 | We report a case of eosinophilic myocarditis manifesting as st-elevation myocardial infarction (stemi) with cardiogenic shock treated successfully with steroids. |
| PubMedID- 22739496 | Objectives: acute st elevation myocardial infarction (stemi) presenting with cardiogenic shock (cs) is associated with dismal prognosis. |
| PubMedID- 22767014 | The successful combined use of impella lp 2.5 and intra-aortic balloon pump in st-elevation myocardial infarction with refractory cardiogenic shock. |
| PubMedID- 23940425 | Background: the clinical outcome of patients with myocardial infarction (mi) complicated by cardiogenic shock (cs) who require mechanical ventilation (mv) is poor. |
| PubMedID- 22263168 | Background: despite aggressive treatment, the mortality rate of cardiogenic shock with acute myocardial infarction (ami) is high. |
| PubMedID- 19108906 | We report a case of emergent percutaneous intervention to a cabrol graft-left main anastomosis in a patient who presented with acute myocardial infarction complicated by cardiogenic shock. |